|
1
|
Rajamäki K, Taira A, Katainen R, Välimäki
N, Kuosmanen A, Plaketti RM, Seppälä TT, Ahtiainen M, Wirta EV,
Vartiainen E, et al: Genetic and epigenetic characteristics of
inflammatory bowel Disease-associated colorectal cancer.
Gastroenterology. 161:592–607. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang L, Wu G, Wu Q, Peng L and Yuan L:
METTL3 overexpression aggravates LPS-induced cellular inflammation
in mouse intestinal epithelial cells and DSS-induced IBD in mice.
Cell Death Discov. 8:622022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Patankar JV, Müller TM, Kantham S, Acera
MG, Mascia F, Scheibe K, Mahapatro M, Heichler C, Yu Y, Li W, et
al: E-type prostanoid receptor 4 drives resolution of intestinal
inflammation by blocking epithelial necroptosis. Nat Cell Biol.
23:796–807. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Yim AYF, Duijvis NW, Zhao J, de Jonge
WJ, D'Haens GRAM, Mannens MMAM, Mul ANPM, Te Velde AA and Henneman
P: Peripheral blood methylation profiling of female Crohn's disease
patients. Clin Epigenetics. 8:652016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nóbrega VG, Silva INN, Brito BS, Silva J,
Silva M and Santana GO: The onset of clinical manifestations in
inflammatory bowel disease patients. Arq Gastroenterol. 55:290–295.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ng SC, Shi HY, Hamidi N, Underwood FE,
Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, et
al: Worldwide incidence and prevalence of inflammatory bowel
disease in the 21st century: A systematic review of
population-based studies. Lancet. 390:2769–2778. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gearry RB: IBD and environment: Are there
differences between east and west. Dig Dis. 34:84–89. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park SC and Jeen YT: Genetic studies of
inflammatory bowel Disease-focusing on Asian patients. Cells.
8:4042019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsuoka K and Kanai T: The gut microbiota
and inflammatory bowel disease. Semin Immunopathol. 37:47–55. 2015.
View Article : Google Scholar :
|
|
10
|
Rindflesch TC, Blake CL, Cairelli MJ,
Fiszman M, Zeiss CJ and Kilicoglu H: Investigating the role of
interleukin-1 beta and glutamate in inflammatory bowel disease and
epilepsy using discovery browsing. J Biomed Semantics. 9:252018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bank S, Julsgaard M, Abed OK, Burisch J,
Broder Brodersen J, Pedersen NK, Gouliaev A, Ajan R, Nytoft
Rasmussen D, Honore Grauslund C, et al: Polymorphisms in the NFkB,
TNF-alpha, IL-1beta, and IL-18 pathways are associated with
response to anti-TNF therapy in Danish patients with inflammatory
bowel disease. Aliment Pharmacol Ther. 49:890–903. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Z and Wang H: Probiotics alleviate
inflammatory bowel disease in mice by regulating intestinal
microorganisms-bile acid-NLRP3 inflammasome pathway. Acta Biochim
Pol. 68:687–693. 2021.PubMed/NCBI
|
|
13
|
Cooke J, Zhang H, Greger L, Silva AL,
Massey D, Dawson C, Metz A, Ibrahim A and Parkes M: Mucosal
genome-wide methylation changes in inflammatory bowel disease.
Inflamm Bowel Dis. 18:2128–2137. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin Z, Hegarty JP, Yu W, Cappel JA, Chen
X, Faber PW, Wang Y, Poritz LS, Fan JB and Koltun WA:
Identification of disease-associated DNA methylation in B cells
from Crohn's disease and ulcerative colitis patients. Dig Dis Sci.
57:3145–3153. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang K, Zhang H, Kugathasan S, Annese V,
Bradfield JP, Russell RK, Sleiman PM, Imielinski M, Glessner J, Hou
C, et al: Diverse genome-wide association studies associate the
IL12/IL23 pathway with Crohn disease. Am J Hum Genet. 84:399–405.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim SW, Kim ES, Moon CM, Park JJ, Kim TI,
Kim WH and Cheon JH: Genetic polymorphisms of IL-23R and IL-17A and
novel insights into their associations with inflammatory bowel
disease. Gut. 60:1527–1536. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bae JH, Park J, Yang KM, Kim TO and Yi JM:
Detection of DNA hypermethylation in sera of patients with Crohn's
disease. Mol Med Rep. 9:725–729. 2014. View Article : Google Scholar
|
|
18
|
Sanati G, Jafari D, Noruzinia M, Ebrahimi
Daryani N, Ahmadvand M, Teimourian S and Rezaei N: Association of
aberrant promoter methylation changes in the suppressor of cytokine
signaling 3 (SOCS3) gene with susceptibility to Crohn's disease.
Avicenna J Med Biotechnol. 14:165–169. 2022.PubMed/NCBI
|
|
19
|
Yousefi PD, Suderman M, Langdon R,
Whitehurst O, Davey Smith G and Relton CL: DNA methylation-based
predictors of health: Applications and statistical considerations.
Nat Rev Genet. 23:369–383. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang S, Fu J and Fang X: A novel DNA
methylation-related gene signature for the prediction of overall
survival and immune characteristics of ovarian cancer patients. J
Ovarian Res. 16:622023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pan Y, Liu G, Zhou F, Su B and Li Y: DNA
methylation profiles in cancer diagnosis and therapeutics. Clin Exp
Med. 18:1–14. 2018. View Article : Google Scholar
|
|
22
|
Glezeva N, Moran B, Collier P, Moravec CS,
Phelan D, Donnellan E, Russell-Hallinan A, O'Connor DP, Gallagher
WM, Gallagher J, et al: Targeted DNA methylation profiling of human
cardiac tissue reveals novel epigenetic traits and gene
deregulation across different heart failure patient subtypes. Circ
Heart Fail. 12:e0057652019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang Z, Yang Y, Zhang Q and Liang T:
Epigenetic dysregulation-mediated COL12A1 upregulation predicts
worse outcome in intrahepatic cholangiocarcinoma patients. Clin
Epigenetics. 15:132023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Smail HO and Mohamad DA: Identification of
DNA methylation change in TCF7L2 gene in the blood of type 2
diabetes mellitus as a predictive biomarker in Iraq Kurdistan
region by using methylation-specific PCR. Endocr Regul. 57:53–60.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ehtesham N, Habibi Kavashkohie MR, Mazhari
SA, Azhdari S, Ranjbar H, Mosallaei M, Hazrati E and Behroozi J:
DNA methylation alterations in systemic lupus erythematosus: A
systematic review of case-control studies. Lupus. 32:363–379. 2023.
View Article : Google Scholar
|
|
26
|
Xu HM, Xu J, Yang MF, Liang YJ, Peng QZ,
Zhang Y, Tian CM, Nie YQ, Wang LS, Yao J and Li DF: Epigenetic DNA
methylation of Zbtb7b regulates the population of double-positive
CD4+CD8+ T cells in ulcerative colitis. J
Transl Med. 20:2892022. View Article : Google Scholar
|
|
27
|
Lin Y, Lin L, Yang Y, Guo Q, Long Y, He H,
Bao Y, Lin T, Chen J, Chen Z, et al: DNA methylation architecture
provides insight into the pathogenesis of upper tract urothelial
carcinoma: A systematic review and Meta-Analysis. Clin Genitourin
Cancer. 21:32–42. 2023. View Article : Google Scholar
|
|
28
|
Aquino EM, Benton MC, Haupt LM, Sutherland
HG, Griffiths LR and Lea RA: Current understanding of DNA
methylation and age-related disease. OBM Genetics. 2:1–16. 2018.
View Article : Google Scholar
|
|
29
|
Lin CC, Chen YP, Yang WZ, Shen JCK and
Yuan HS: Structural insights into CpG-specific DNA methylation by
human DNA methyltransferase 3B. Nucleic Acids Res. 48:3949–3961.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Uysal F, Sukur G and Cinar O: DNMT enzymes
differentially alter global DNA methylation in a stage-dependent
manner during spermatogenesis. Andrologia. 54:e143572022.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fujii S, Katake Y and Tanaka H: Increased
expression of DNA methyltransferase-1 in non-neoplastic epithelium
helps predict colorectal neoplasia risk in ulcerative colitis.
Digestion. 82:179–186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saito S, Kato J, Hiraoka S, Horii J,
Suzuki H, Higashi R, Kaji E, Kondo Y and Yamamoto K: DNA
methylation of colon mucosa in ulcerative colitis patients:
Correlation with inflammatory status. Inflamm Bowel Dis.
17:1955–1965. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Scarpa M, Scarpa M, Castagliuolo I, Erroi
F, Kotsafti A, Basato S, Brun P, D'Incà R, Rugge M, Angriman I and
Castoro C: Aberrant gene methylation in non-neoplastic mucosa as a
predictive marker of ulcerative colitis-associated CRC. Oncotarget.
7:10322–10331. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ueda H, Tanaka H, Ichikawa K, Itabashi M,
Kameoka S, Fujii S, Saito N, Kimura R, Shida Y, Fujimori Y, et al:
Immunohistochemical analysis of the DNA methyltransferase 3b
expression is associated with significant improvements in the
discrimination of ulcerative colitis-associated neoplastic lesions.
Surg Today. 43:1275–1280. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lv Q, Shi C, Qiao S, Cao N, Guan C, Dai Y
and Wei Z: Alpinetin exerts anti-colitis efficacy by activating
AhR, regulating miR-302/DNMT-1/CREB signals, and therefore
promoting Treg differentiation. Cell Death Dis. 9:8902018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Foran E, Garrity-Park MM, Mureau C, Newell
J, Smyrk TC, Limburg PJ and Egan LJ: Upregulation of DNA
methyltransferase-mediated gene silencing, anchorage-independent
growth, and migration of colon cancer cells by interleukin-6. Mol
Cancer Res. 8:471–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang Q, Wang HY, Woetmann A, Raghunath
PN, Odum N and Wasik MA: STAT3 induces transcription of the DNA
methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood.
108:1058–1064. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang Q, Wang HY, Marzec M, Raghunath PN,
Nagasawa T and Wasik MA: STAT3- and DNA methyltransferase
1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor
suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci USA.
102:6948–6953. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Doi R, Fukumura Y, Lu R, Hirabayashi K,
Kinowaki Y, Nakanuma Y, Kanai Y, Nakahodo J, Sasahara N, Saito T
and Yao T: DNMT1 expression and DNA methylation in intraductal
papillary neoplasms of the bile duct. Anticancer Res. 42:2893–2902.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fazio A, Bordoni D, Kuiper JWP,
Weber-Stiehl S, Stengel ST, Arnold P, Ellinghaus D, Ito G, Tran F,
Messner B, et al: DNA methyltransferase 3A controls intestinal
epithelial barrier function and regeneration in the colon. Nat
Commun. 13:62662022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Y, Ma L, Deng Y, Du Z, Guo B, Yue J,
Liu X and Zhang Y: The Notch1/Hes1 signaling pathway affects
autophagy by adjusting DNA methyltransferases expression in a
valproic acid-induced autism spectrum disorder model.
Neuropharmacology. 239:1096822023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lio CJ and Rao A: TET Enzymes and 5hmC in
adaptive and innate immune systems. Front Immunol. 10:2102019.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gonzalez EA, Liu Y, Wang D, Jeziorek M,
Bandyopadhyay S, Rao A, Gao N and Etchegaray JP: TET3-mediated DNA
oxidation is essential for intestinal epithelial cell response to
stressors. Proc Natl Acad Sci USA. 120:e22214051202023. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
El-Harakeh M, Saliba J, Sharaf Aldeen K,
Haidar M, El Hajjar L, Awad MK, Hashash JG, Shirinian M and
El-Sabban M: Expression of the methylcytosine dioxygenase
ten-eleven translocation-2 and connexin 43 in inflammatory bowel
disease and colorectal cancer. World J Gastroenterol. 28:5845–5864.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sharaf Al Deen K: TET2 Expression as a
function of Cx43 regulation: An in-vitro archival tissue study of
IBD and human colon cancer. 2020, http://hdl.handle.net/10938/21961.
|
|
46
|
Takeshima H, Niwa T, Yamashita S,
Takamura-Enya T, Iida N, Wakabayashi M, Nanjo S, Abe M, Sugiyama T,
Kim YJ and Ushijima T: TET repression and increased DNMT activity
synergistically induce aberrant DNA methylation. J Clin Invest.
130:5370–5379. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li X, Li Z, Gao Q, Peng Y, Yu Y, Hu T and
Wang W: Correlation of DNA methylation of DNMT3A and TET2 with oral
squamous cell carcinoma. Discov Oncol. 15:152024. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ansari I, Solé-Boldo L, Ridnik M,
Gutekunst J, Gilliam O, Korshko M, Liwinski T, Jickeli B,
Weinberg-Corem N, Shoshkes-Carmel M, et al: TET2 and TET3 loss
disrupts small intestine differentiation and homeostasis. Nat
Commun. 14:40052023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gupta T, Morgan HR, Bailey JA and Certel
SJ: Functional conservation of MBD proteins: MeCP2 and Drosophila
MBD proteins alter sleep. Genes Brain Behav. 15:757–774. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ludwig AK, Zhang P, Hastert FD, Meyer S,
Rausch C, Herce HD, Müller U, Lehmkuhl A, Hellmann I, Trummer C, et
al: Binding of MBD proteins to DNA blocks Tet1 function thereby
modulating transcriptional noise. Nucleic Acids Res. 45:2438–2457.
2017. View Article : Google Scholar :
|
|
51
|
Wang LS, Kuo CT, Stoner K, Yearsley M,
Oshima K, Yu J, Huang TH, Rosenberg D, Peiffer D, Stoner G and
Huang YW: Dietary black raspberries modulate DNA methylation in
dextran sodium sulfate (DSS)-induced ulcerative colitis.
Carcinogenesis. 34:2842–2850. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
McGovern D and Powrie F: The IL23 axis
plays a key role in the pathogenesis of IBD. Gut. 56:1333–1336.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen M, Zhu H, Mao YJ, Cao N, Yu YL, Li
LY, Zhao Q, Wu M and Ye M: Regulation of IL12B expression in human
macrophages by TALEN-mediated epigenome editing. Curr Med Sci.
40:900–909. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Duerr RH, Taylor KD, Brant SR, Rioux JD,
Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M,
Griffiths A, et al: A genome-wide association study identifies
IL23R as an inflammatory bowel disease gene. Science.
314:1461–1463. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Pidasheva S, Trifari S, Phillips A,
Hackney JA, Ma Y, Smith A, Sohn SJ, Spits H, Little RD, Behrens TW,
et al: Functional studies on the IBD susceptibility gene IL23R
implicate reduced receptor function in the protective genetic
variant R381Q. PLoS One. 6:e250382011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Dhir M, Montgomery EA, Glöckner SC,
Schuebel KE, Hooker CM, Herman JG, Baylin SB, Gearhart SL and Ahuja
N: Epigenetic regulation of WNT signaling pathway genes in
inflammatory bowel disease (IBD) associated neoplasia. J
Gastrointest Surg. 12:1745–1753. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yoshimi K, Tanaka T, Serikawa T and
Kuramoto T: Tumor suppressor APC protein is essential in mucosal
repair from colonic inflammation through angiogenesis. Am J Pathol.
182:1263–1274. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li H, Zhao J, Sun J, Tian C, Jiang Q, Ding
C, Gan Q, Shu P, Wang X, Qin J and Sun Y: Demethylation of the
SFRP4 promoter drives gastric cancer progression via the Wnt
pathway. Mol Cancer Res. 19:1454–1464. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Deshmukh A, Arfuso F, Newsholme P and
Dharmarajan A: Epigenetic demethylation of sFRPs, with emphasis on
sFRP4 activation, leading to Wnt signalling suppression and histone
modifications in breast, prostate, and ovary cancer stem cells. Int
J Biochem Cell Biol. 109:23–32. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kim TO, Han YK and Yi JM: Hypermethylated
promoters of tumor suppressor genes were identified in Crohn's
disease patients. Intest Res. 18:297–305. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Li Y, Deuring J, Peppelenbosch MP, Kuipers
EJ, de Haar C and van der Woude CJ: IL-6-induced DNMT1 activity
mediates SOCS3 promoter hypermethylation in ulcerative
colitis-related colorectal cancer. Carcinogenesis. 33:1889–1896.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Li J, Su X, Dai L, Chen N, Fang C, Dong Z,
Fu J, Yu Y, Wang W, Zhang H, et al: Temporal DNA methylation
pattern and targeted therapy in colitis-associated cancer.
Carcinogenesis. 41:235–244. 2020. View Article : Google Scholar
|
|
63
|
Huang YS, Jie N, Zhang YX, Zou KJ and Weng
Y: shRNA-induced silencing of Ras-related C3 botulinum toxin
substrate 1 inhibits the proliferation of colon cancer cells
through upregulation of BAD and downregulation of cyclin D1. Int J
Mol Med. 41:1397–1408. 2018.
|
|
64
|
Somineni HK, Venkateswaran S, Kilaru V,
Marigorta UM, Mo A, Okou DT, Kellermayer R, Mondal K, Cobb D,
Walters TD, et al: Blood-Derived DNA methylation signatures of
Crohn's disease and severity of intestinal inflammation.
Gastroenterology. 156:2254–2265.e3. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Venkateswaran S, Somineni HK, Kilaru V,
Katrinli S, Prince J, Okou DT, Hyams JS, Denson LA, Kellermayer R,
Gibson G, et al: Methylation quantitative trait loci are largely
consistent across disease states in Crohn's disease. G3 (Bethesda).
12:jkac0412022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Tan ZY and Ding M: DNA extraction from
formalin fixed and paraffin embedded tissues. Fa Yi Xue Za Zhi.
22:455–458. 2006.In Chinese.
|
|
67
|
Berrino E, Bellomo SE, Chesta A, Detillo
P, Bragoni A, Gagliardi A, Naccarati A, Cereda M, Witel G, Sapino
A, et al: Alternative tissue fixation protocols dramatically reduce
the impact of DNA artifacts, unraveling the interpretation of
clinical comprehensive genomic profiling. Lab Invest.
104:1002802024. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Azuara D, Rodriguez-Moranta F, de Oca J,
Sanjuan X, Guardiola J, Lobaton T, Wang A, Boadas J, Piqueras M,
Monfort D, et al: Novel methylation panel for the early detection
of neoplasia in high-risk ulcerative colitis and Crohn's colitis
patients. Inflamm Bowel Dis. 19:165–173. 2013. View Article : Google Scholar
|
|
69
|
Azuara D, Aussó S, Rodriguez-Moranta F,
Guardiola J, Sanjuan X, Lobaton T, Boadas J, Piqueras M, Monfort D,
Guinó E, et al: New methylation biomarker panel for early diagnosis
of dysplasia or cancer in High-risk inflammatory bowel disease
patients. Inflamm Bowel Dis. 24:2555–2564. 2018.PubMed/NCBI
|
|
70
|
Johnson DH, Taylor WR, Aboelsoud MM, Foote
PH, Yab TC, Cao X, Smyrk TC, Loftus EV Jr, Mahoney DW, Ahlquist DA
and Kisiel JB: DNA methylation and mutation of small colonic
neoplasms in ulcerative colitis and Crohn's colitis: Implications
for surveillance. Inflamm Bowel Dis. 22:1559–1567. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Maeda O, Ando T, Watanabe O, Ishiguro K,
Ohmiya N, Niwa Y and Goto H: DNA hypermethylation in colorectal
neoplasms and inflammatory bowel disease: A mini review.
Inflammopharmacology. 14:204–206. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kisiel JB, Yab TC, Nazer Hussain FT,
Taylor WR, Garrity-Park MM, Sandborn WJ, Loftus EV, Wolff BG, Smyrk
TC, Itzkowitz SH, et al: Stool DNA testing for the detection of
colorectal neoplasia in patients with inflammatory bowel disease.
Aliment Pharmacol Ther. 37:546–554. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Kang K, Bae JH, Han K, Kim ES, Kim TO and
Yi JM: A Genome-wide methylation approach identifies a new
hypermethylated gene panel in ulcerative colitis. Int J Mol Sci.
17:12912016. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Dooley TP, Curto EV, Reddy SP, Davis RL,
Lambert GW, Wilborn TW and Elson CO: Regulation of gene expression
in inflammatory bowel disease and correlation with IBD drugs:
Screening by DNA microarrays. Inflamm Bowel Dis. 10:1–14. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Joustra V, Li Yim AYF, Hageman I, Levin E,
Adams A, Satsangi J, de Jonge WJ, Henneman P and D'Haens G:
Long-term temporal stability of peripheral blood DNA methylation
profiles in patients with inflammatory bowel disease. Cell Mol
Gastroenterol Hepatol. 15:869–885. 2023. View Article : Google Scholar :
|
|
76
|
Pekow J, Hernandez K, Meckel K, Deng Z,
Haider HI, Khalil A, Zhang C, Talisila N, Siva S, Jasmine F, et al:
IBD-associated colon cancers differ in DNA methylation and gene
expression profiles compared with sporadic colon cancers. J Crohns
Colitis. 13:884–893. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Lin S, Hannon E, Reppell M, Waring JF,
Smaoui N, Pivorunas V, Guay H, Chanchlani N, Bewshea C, Bai BYH, et
al: Whole blood DNA methylation changes are associated with
anti-TNF drug concentration in patients with Crohn's disease. J
Crohns Colitis. jjad1332003. View Article : Google Scholar : Epub ahead of
print.
|
|
78
|
Mishra N, Aden K, Blase JI, Baran N,
Bordoni D, Tran F, Conrad C, Avalos D, Jaeckel C, Scherer M, et al:
Longitudinal Multi-omics analysis identifies early blood-based
predictors of anti-TNF therapy response in inflammatory bowel
disease. Genome Med. 14:1102022. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
McDermott E, Ryan EJ, Tosetto M, Gibson D,
Burrage J, Keegan D, Byrne K, Crowe E, Sexton G, Malone K, et al:
DNA methylation profiling in inflammatory bowel disease provides
new insights into disease pathogenesis. J Crohns Colitis. 10:77–86.
2016. View Article : Google Scholar :
|
|
80
|
Vlantis K, Polykratis A, Welz PS, van Loo
G, Pasparakis M and Wullaert A: TLR-independent anti-inflammatory
function of intestinal epithelial TRAF6 signalling prevents
DSS-induced colitis in mice. Gut. 65:935–943. 2016. View Article : Google Scholar
|
|
81
|
Kunz M, König IR, Schillert A, Kruppa J,
Ziegler A, Grallert H, Müller-Nurasyid M, Lieb W, Franke A, Ranki
A, et al: Genome-wide association study identifies new
susceptibility loci for cutaneous lupus erythematosus. Exp
Dermatol. 24:510–515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Polani S, Dean M, Lichter-Peled A,
Hendrickson S, Tsang S, Fang X, Feng Y, Qiao W, Avni G and Kahila
Bar-Gal G: Sequence variant in the TRIM39-RPP21 gene readthrough is
shared across a cohort of Arabian foals diagnosed with juvenile
idiopathic epilepsy. J Genet Mutat Disord. 1:1032022.PubMed/NCBI
|
|
83
|
Nimmo ER, Prendergast JG, Aldhous MC,
Kennedy NA, Henderson P, Drummond HE, Ramsahoye BH, Wilson DC,
Semple CA and Satsangi J: Genome-wide methylation profiling in
Crohn's disease identifies altered epigenetic regulation of key
host defense mechanisms including the Th17 pathway. Inflamm Bowel
Dis. 18:889–899. 2012. View Article : Google Scholar
|
|
84
|
Coit P, De Lott LB, Nan B, Elner VM and
Sawalha AH: DNA methylation analysis of the temporal artery
microenvironment in giant cell arteritis. Ann Rheum Dis.
75:1196–1202. 2016. View Article : Google Scholar
|
|
85
|
Wang Y, Jiang X, Zhu J, Dan Yue, Zhang X,
Wang X, You Y, Wang B, Xu Y, Lu C, et al: IL-21/IL-21R signaling
suppresses intestinal inflammation induced by DSS through
regulation of Th responses in lamina propria in mice. Sci Rep.
6:318812016. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Holm TL, Tornehave D, Søndergaard H, Kvist
PH, Sondergaard BC, Hansen L, Hermit MB, Holgersen K, Vergo S,
Frederiksen KS, et al: Evaluating IL-21 as a potential therapeutic
target in Crohn's disease. Gastroenterol Res Pract.
2018:59626242018. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Toskas A, Milias S, Delis G, Meditskou S,
Sioga A and Papamitsou T: Expression of IL-21 and IL-33 in
intestinal mucosa of inflammatory bowel disease: An
immunohistochemical study. Diagnostics (Basel). 13:21852023.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Yang S, Zeng J, Hao W, Sun R, Tuo Y, Tan
L, Zhang H, Liu R and Bai H: IL-21/IL-21R promotes the
Pro-Inflammatory effects of macrophages during C. muridarum
respiratory infection. Int J Mol Sci. 24:125572023. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Li Y, de Haar C, Peppelenbosch MP and van
der Woude CJ: SOCS3 in immune regulation of inflammatory bowel
disease and inflammatory bowel disease-related cancer. Cytokine
Growth Factor Rev. 23:127–138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhou L, Yan Z, Yang W, Buckley JA, Al
Diffalha S, Benveniste EN and Qin H: Socs3 expression in myeloid
cells modulates the pathogenesis of dextran sulfate sodium
(DSS)-induced colitis. Front Immunol. 14:11639872023. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zheng H, Yan Y, Cheng J, Yu S and Wang Y:
Association between SOCS3 hypermethylation and HBV-related
hepatocellular carcinoma and effect of sex and age: A
meta-analysis. Medicine. 100:e276042021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Gonsky R, Deem RL and Targan SR: Distinct
methylation of IFNG in the gut. J Interferon Cytokine Res.
29:407–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Gonsky R, Deem RL, Landers CJ, Haritunians
T, Yang S and Targan SR: IFNG rs1861494 polymorphism is associated
with IBD disease severity and functional changes in both IFNG
methylation and protein secretion. Inflamm Bowel Dis. 20:1794–1801.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Hashimoto H, Watanabe M, Inoue N, Hirai N,
Haga E, Kinoshita R, Hidaka Y and Iwatani Y: Association of IFNG
gene methylation in peripheral blood cells with the development and
prognosis of autoimmune thyroid diseases. Cytokine. 123:1547702019.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Chen L, Chen J, Mo F, Bian Z, Jin C, Chen
X and Liang C: Genetic polymorphisms of IFNG, IFNGR1, and androgen
receptor and chronic prostatitis/chronic pelvic pain syndrome in a
Chinese Han population. Dis Markers. 2021:28983362021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Papadia C, Louwagie J, Del Rio P,
Grooteclaes M, Coruzzi A, Montana C, Novelli M, Bordi C, de'
Angelis GL, Bassett P, et al: FOXE1 and SYNE1 genes
hypermethylation panel as promising biomarker in colitis-associated
colorectal neoplasia. Inflamm Bowel Dis. 20:271–277. 2014.
View Article : Google Scholar
|
|
97
|
Dhir M, Yachida S, Van Neste L, Glöckner
SC, Jeschke J, Pappou EP, Montgomery EA, Herman JG, Baylin SB,
Iacobuzio-Donahue C and Ahuja N: Sessile serrated adenomas and
classical adenomas: An epigenetic perspective on premalignant
neoplastic lesions of the gastrointestinal tract. Int J Cancer.
129:1889–1898. 2011. View Article : Google Scholar :
|
|
98
|
Weisenberger DJ, Trinh BN, Campan M,
Sharma S, Long TI, Ananthnarayan S, Liang G, Esteva FJ, Hortobagyi
GN, McCormick F, et al: DNA methylation analysis by digital
bisulfite genomic sequencing and digital MethyLight. Nucleic Acids
Res. 36:4689–4698. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Venza I, Visalli M, Tripodo B, De Grazia
G, Loddo S, Teti D and Venza M: FOXE1 is a target for aberrant
methylation in cutaneous squamous cell carcinoma. Br J Dermatol.
162:1093–1097. 2010. View Article : Google Scholar
|
|
100
|
Qu Y, Gao N and Wu T: Expression and
clinical significance of SYNE1 and MAGI2 gene promoter methylation
in gastric cancer. Medicine. 100:e237882021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Yi JM, Dhir M, Guzzetta AA,
Iacobuzio-Donahue CA, Heo K, Yang KM, Suzuki H, Toyota M, Kim HM
and Ahuja N: DNA methylation biomarker candidates for early
detection of colon cancer. Tumour Biol. 33:363–372. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Kim TO, Park J, Kang MJ, Lee SH, Jee SR,
Ryu DY, Yang K and Yi JM: DNA hypermethylation of a selective gene
panel as a risk marker for colon cancer in patients with ulcerative
colitis. Int J Mol Med. 31:1255–1261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Alafaria HAA and Jalal AS: Novel DNA
methylation biomarkers for early diagnosis of oral tongue squamous
cell carcinoma (OTSCC). J Appl Genet. Mar 5–2024. View Article : Google Scholar : Epub ahead of
print.
|
|
104
|
Liu F, Lu X, Zhou X and Huang H: APC gene
promoter methylation as a potential biomarker for lung cancer
diagnosis: A meta-analysis. Thoracic Cancer. 12:2907–2913. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Cai C, Zhu Y, Mu J, Liu S, Yang Z, Wu Z,
Zhao C, Song X, Ye Y, Gu J, et al: DNA methylation of RUNX3
promotes the progression of gallbladder cancer through repressing
SLC7A11-mediated ferroptosis. Cell Signal. 108:1107102023.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Toyooka S, Toyooka KO, Harada K, Miyajima
K, Makarla P, Sathyanarayana UG, Yin J, Sato F, Shivapurkar N,
Meltzer SJ and Gazdar AF: Aberrant methylation of the CDH13
(H-cadherin) promoter region in colorectal cancers and adenomas.
Cancer Res. 62:3382–3386. 2002.PubMed/NCBI
|
|
107
|
Kim TO, Park DI, Han YK, Kang K, Park SG,
Park HR and Yi JM: Genome-Wide analysis of the DNA methylation
profile identifies the fragile histidine triad (FHIT) gene as a new
promising biomarker of Crohn's disease. J Clin Med. 9:13382020.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Bellon M, Bialuk I, Galli V, Bai XT, Farre
L, Bittencourt A, Marçais A, Petrus MN, Ratner L, Waldmann TA, et
al: Germinal epimutation of Fragile Histidine Triad (FHIT) gene is
associated with progression to acute and chronic adult T-cell
leukemia diseases. Mol Cancer. 20:862021. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Zhang Y, Xu X, Chen Z and Zhao Z:
Association of FHIT expression and FHIT gene hypermethylation with
liver cancer risk: A PRISMA-compliant meta-analysis. Onco Targets
Ther. 10:3083–3093. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Wu X, Wu G, Yao X, Hou G and Jiang F: The
clinicopathological significance and ethnic difference of FHIT
hypermethylation in non-small-cell lung carcinoma: A meta-analysis
and literature review. Drug Des Devel Ther. 10:699–709.
2016.PubMed/NCBI
|
|
111
|
Gerecke C, Scholtka B, Löwenstein Y, Fait
I, Gottschalk U, Rogoll D, Melcher R and Kleuser B:
Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is
increased in inflamed colon tissue: Putative risk markers for
colitisassociated cancer. J Cancer Res Clin Oncol. 141:2097–2107.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Ausch C, Kim YH, Tsuchiya KD,
Dzieciatkowski S, Washington MK, Paraskeva C, Radich J and Grady
WM: Comparative analysis of PCR-based biomarker assay methods for
colorectal polyp detection from fecal DNA. Clin Chem. 55:1559–1563.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Bretz N, Noske A, Keller S, Erbe-Hofmann
N, Schlange T, Salnikov AV, Moldenhauer G, Kristiansen G and
Altevogt P: CD24 promotes tumor cell invasion by suppressing tissue
factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.
Clin Exp Metastasis. 29:27–38. 2012. View Article : Google Scholar
|
|
114
|
Enders A, Stankovic S, Teh C, Uldrich AP,
Yabas M, Juelich T, Altin JA, Frankenreiter S, Bergmann H, Roots
CM, et al: ZBTB7B (Th-POK) regulates the development of
IL-17-producing CD1d-restricted mouse NKT cells. J Immunol.
189:5240–5249. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Wildt KF, Sun G, Grueter B, Fischer M,
Zamisch M, Ehlers M and Bosselut R: The transcription factor Zbtb7b
promotes CD4 expression by antagonizing Runx-mediated activation of
the CD4 silencer. J Immunol. 179:4405–4414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Dang Do AN, Sleat DE, Campbell K, Johnson
NL, Zheng H, Wassif CA, Dale RK and Porter FD: Cerebrospinal fluid
protein biomarker discovery in CLN3. J Proteome Res. 22:2493–2508.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Li N, Yu K, Lin Z and Zeng D: Identifying
a cervical cancer survival signature based on mRNA expression and
genome-wide copy number variations. Exp Biol Med (Maywood).
247:207–220. 2022. View Article : Google Scholar
|
|
118
|
Pernat Drobež C, Repnik K, Gorenjak M,
Ferkolj I, Weersma RK and Potočnik U: DNA polymorphisms predict
time to progression from uncomplicated to complicated Crohn's
disease. Eur J Gastroenterol Hepatol. 30:447–455. 2018. View Article : Google Scholar
|
|
119
|
Harris RA, Nagy-Szakal D, Mir SA, Frank E,
Szigeti R, Kaplan JL, Bronsky J, Opekun A, Ferry GD, Winter H and
Kellermayer R: DNA methylation-associated colonic mucosal immune
and defense responses in treatment-naïve pediatric ulcerative
colitis. Epigenetics. 9:1131–1137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Okahara S, Arimura Y, Yabana T, Kobayashi
K, Gotoh A, Motoya S, Imamura A, Endo T and Imai K: Inflammatory
gene signature in ulcerative colitis with cDNA macroarray analysis.
Aliment Pharmacol Ther. 21:1091–1097. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Román J, Planell N, Lozano JJ, Aceituno M,
Esteller M, Pontes C, Balsa D, Merlos M, Panés J and Salas A:
Evaluation of responsive gene expression as a sensitive and
specific biomarker in patients with ulcerative colitis. Inflamm
Bowel Dis. 19:221–229. 2013. View Article : Google Scholar
|
|
122
|
Ventham NT, Kennedy NA, Adams AT, Kalla R,
Heath S, O'Leary KR, Drummond H; IBD BIOM consortium; IBD CHARACTER
consortium; Wilson DC; et al: Integrative epigenome-wide analysis
demonstrates that DNA methylation may mediate genetic risk in
inflammatory bowel disease. Nat Commun. 7:135072016. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Zhu L, Zhu C, Jin J, Wang J, Zhao X and
Yang R: Identification of an association between coronary heart
disease and ITGB2 methylation in peripheral blood by a case-control
study. Clin Chim Acta. 552:1176272024. View Article : Google Scholar
|
|
124
|
Xing XL, Liu Y, Liu J, Zhou H, Zhang H,
Zuo Q, Bu P, Duan T, Zhou Y and Xiao Z: Comprehensive analysis of
ferroptosis- and immune-related signatures to improve the prognosis
and diagnosis of kidney renal clear cell carcinoma. Front Immunol.
13:8513122022. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Peng C, Zhao G, Pei B, Wang K, Li H, Fei
S, Song L, Wang C, Xiong S, Xue Y, et al: A novel plasma-based
methylation panel for upper gastrointestinal cancer early
detection. Cancers (Basel). 14:52822022. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Sun FK, Sun Q, Fan YC, Gao S, Zhao J, Li
F, Jia YB, Liu C, Wang LY, Li XY, et al: Methylation of tissue
factor pathway inhibitor 2 as a prognostic biomarker for
hepatocellular carcinoma after hepatectomy. J Gastroenterol
Hepatol. 31:484–492. 2016. View Article : Google Scholar
|
|
127
|
Karamitrousis EI, Balgkouranidou I,
Xenidis N, Amarantidis K, Biziota E, Koukaki T, Trypsianis G,
Karayiannakis A, Bolanaki H, Kolios G, et al: Prognostic role of
RASSF1A, SOX17 and Wif-1 promoter methylation status in Cell-Free
DNA of advanced gastric cancer patients. Technol Cancer Res Treat.
20:15330338209732792021. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Jia Y, Yang Y, Liu S, Herman JG, Lu F and
Guo M: SOX17 antagonizes WNT/β-catenin signaling pathway in
hepatocellular carcinoma. Epigenetics. 5:743–749. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Hata T, Mizuma M, Kusakabe T, Amano H,
Furukawa T, Iwao T and Unno M: Simultaneous and sequential
combination of genetic and epigenetic biomarkers for the presence
of high-grade dysplasia in patients with pancreatic cyst: Discovery
in cyst fluid and test in pancreatic juice. Pancreatology.
23:218–226. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Akiyama Y, Watkins N, Suzuki H, Jair KW,
van Engeland M, Esteller M, Sakai H, Ren CY, Yuasa Y, Herman JG and
Baylin SB: GATA-4 and GATA-5 transcription factor genes and
potential downstream antitumor target genes are epigenetically
silenced in colorectal and gastric cancer. Mol Cell Biol.
23:8429–8439. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Karatzas PS, Mantzaris GJ, Safioleas M and
Gazouli M: DNA methylation profile of genes involved in
inflammation and autoimmunity in inflammatory bowel disease.
Medicine. 93:e3092014. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Taman H, Fenton CG, Hensel IV, Anderssen
E, Florholmen J and Paulssen RH: Genome-wide DNA methylation in
Treatment-naïve ulcerative colitis. J Crohns Colitis. 12:1338–1347.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Walz A, Schmutz P, Mueller C and
Schnyder-Candrian S: Regulation and function of the CXC chemokine
ENA-78 in monocytes and its role in disease. J Leukoc Biol.
62:604–611. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Friedrich M, Diegelmann J, Schauber J,
Auernhammer CJ and Brand S: Intestinal neuroendocrine cells and
goblet cells are mediators of IL-17A-amplified epithelial IL-17C
production in human inflammatory bowel disease. Mucosal Immunol.
8:943–958. 2015. View Article : Google Scholar
|
|
135
|
West GA, Matsuura T, Levine AD, Klein JS
and Fiocchi C: Interleukin 4 in inflammatory bowel disease and
mucosal immune reactivity. Gastroenterology. 110:1683–1695. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Lin K, Zou R, Lin F, Zheng S, Shen X and
Xue X: Expression and effect of CXCL14 in colorectal carcinoma. Mol
Med Rep. 10:1561–1568. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Huang J, Chen Z, Ding C, Lin S, Wan D and
Ren K: Prognostic biomarkers and immunotherapeutic targets among
CXC chemokines in pancreatic adenocarcinoma. Front Oncol.
11:7114022021. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Samarani S, Dupont-Lucas C, Marcil V, Mack
D, Israel D, Deslandres C, Jantchou P, Ahmad A and Amre D: CpG
Methylation in TGFβ1 and IL-6 genes as surrogate biomarkers for
diagnosis of IBD in Children. Inflamm Bowel Dis. 26:1572–1578.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Marincola Smith P, Choksi YA, Markham NO,
Hanna DN, Zi J, Weaver CJ, Hamaamen JA, Lewis KB, Yang J, Liu Q, et
al: Colon epithelial cell TGFβ signaling modulates the expression
of tight junction proteins and barrier function in mice. Am J
Physiol Gastrointest Liver Physiol. 320:G936–G957. 2021. View Article : Google Scholar
|
|
140
|
Troncone E, Marafini I, Stolfi C and
Monteleone G: Transforming growth Factor-β1/Smad7 in intestinal
immunity, inflammation, and cancer. Front Immunol. 9:14072018.
View Article : Google Scholar
|
|
141
|
Monteleone G, Kumberova A, Croft NM,
McKenzie C, Steer HW and MacDonald TT: Blocking Smad7 restores
TGF-beta1 signaling in chronic inflammatory bowel disease. J Clin
Invest. 108:601–609. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Ivanova MM, Dao J, Slayeh OA, Friedman A
and Goker-Alpan O: Circulated TGF-β1 and VEGF-A as biomarkers for
fabry Disease-associated cardiomyopathy. Cells. 12:21022023.
View Article : Google Scholar
|
|
143
|
Ghobrial EE, Abdel-Aziz HA, Kaddah AM and
Mubarak NA: Urinary transforming growth factor β-1 as a marker of
renal dysfunction in sickle cell disease. Pediatr Neonatol.
57:174–180. 2016. View Article : Google Scholar
|
|
144
|
Chaverri D, Vivas D, Gallardo-Villares S,
Granell-Escobar F, Pinto JA and Vives J: A pilot study of
circulating levels of TGF-β1 and TGF-β2 as biomarkers of bone
healing in patients with non-hypertrophic pseudoarthrosis of long
bones. Bone Reports. 16:1011572022. View Article : Google Scholar
|
|
145
|
Wu DL, Wang Y, Zhang TJ, Chu MQ, Xu ZJ,
Yuan Q, Ma JC, Lin J, Qian J and Zhou JD: SLIT2 promoter
hypermethylation predicts disease progression in chronic myeloid
leukemia. Eur J Med Res. 27:2592022. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Xie S, Zhang Y, Peng T, Guo J, Cao Y, Guo
J, Shi X, Li Y, Liu Y, Qi S and Wang H: TMEFF2 promoter
hypermethylation is an unfavorable prognostic marker in gliomas.
Cancer Cell Int. 21:1482021. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Zhang W, Shang S, Yang Y, Lu P, Wang T,
Cui X and Tang X: Identification of DNA methylation-driven genes by
integrative analysis of DNA methylation and transcriptome data in
pancreatic adenocarcinoma. Exp Ther Med. 19:2963–2972.
2020.PubMed/NCBI
|
|
148
|
Hu H, Chen X, Wang C, Jiang Y, Li J, Ying
X, Yang Y, Li B, Zhou C, Zhong J, et al: The role of TFPI2
hypermethylation in the detection of gastric and colorectal cancer.
Oncotarget. 8:84054–84065. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Gasparetto M, Payne F, Nayak K, Kraiczy J,
Glemas C, Philip-McKenzie Y, Ross A, Edgar RD, Zerbino DR,
Salvestrini C, et al: Transcription and DNA methylation patterns of
Blood-Derived CD8(+) T cells are associated with age and
inflammatory bowel disease but do not predict prognosis.
Gastroenterology. 160:232–244.e7. 2021. View Article : Google Scholar
|
|
150
|
Venkateswaran S, Somineni HK, Matthews JD,
Kilaru V, Hyams JS, Denson LA, Kellamayer R, Gibson G, Cutler DJ,
Conneely KN, et al: Longitudinal DNA methylation profiling of the
rectal mucosa identifies cell-specific signatures of disease
status, severity and clinical outcomes in ulcerative colitis
cell-specific DNA methylation signatures of UC. Clin Epigenetics.
15:502023. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Corridoni D, Antanaviciute A, Gupta T,
Fawkner-Corbett D, Aulicino A, Jagielowicz M, Parikh K, Repapi E,
Taylor S, Ishikawa D, et al: Single-cell atlas of colonic CD8+ T
cells in ulcerative colitis. Nat Med. 26:1480–1490. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Li Yim AYF, Duijvis NW, Ghiboub M, Sharp
C, Ferrero E, Mannens MMAM, D'Haens GR, de Jonge WJ, Te Velde AA
and Henneman P: Whole-genome DNA methylation profiling of CD14+
monocytes reveals disease status and activity differences in
Crohn's disease patients. J Clin Med. 9:10552020. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Grip O, Bredberg A, Lindgren S and
Henriksson G: Increased subpopulations of CD16(+) and CD56(+) blood
monocytes in patients with active Crohn's disease. Inflamm Bowel
Dis. 13:566–572. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Sun Z, Braga-Neto MB, Xiong Y, Bhagwate
AV, Gibbons HR, Sagstetter MR, Hamdan FH, Baheti S, Friton J, Nair
A, et al: Hypomethylation and overexpression of Th17-associated
genes is a hallmark of intestinal CD4+ lymphocytes in Crohn's
disease. J Crohns Colitis. 17:1847–1857. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Howell KJ, Kraiczy J, Nayak KM, Gasparetto
M, Ross A, Lee C, Mak TN, Koo BK, Kumar N, Lawley T, et al: DNA
methylation and transcription patterns in intestinal epithelial
cells from pediatric patients with inflammatory bowel diseases
differentiate disease subtypes and associate with outcome.
Gastroenterology. 154:585–598. 2018. View Article : Google Scholar
|
|
156
|
Mlambo T, Nitsch S, Hildenbeutel M, Romito
M, Müller M, Bossen C, Diederichs S, Cornu TI, Cathomen T and
Mussolino C: Designer epigenome modifiers enable robust and
sustained gene silencing in clinically relevant human cells.
Nucleic Acids Res. 46:4456–4468. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Jinek M, Chylinski K, Fonfara I, Hauer M,
Doudna JA and Charpentier E: A programmable dual-RNA-guided DNA
endonuclease in adaptive bacterial immunity. Science. 337:816–821.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Zhang M, Wang F, Li S, Wang Y, Bai Y and
Xu X: TALE: A tale of genome editing. Prog Biophys Mol Biol.
114:25–32. 2014. View Article : Google Scholar
|
|
159
|
Tang N, Zhang Y, Pedrera M, Chang P,
Baigent S, Moffat K, Shen Z, Nair V and Yao Y: Generating
recombinant avian herpesvirus vectors with CRISPR/Cas9 gene
editing. J Vis Exp. Jan 7–2019. View Article : Google Scholar
|
|
160
|
Kim Y, Kweon J, Kim A, Chon JK, Yoo JY,
Kim HJ, Kim S, Lee C, Jeong E, Chung E, et al: A library of TAL
effector nucleases spanning the human genome. Nat Biotechnol.
31:251–258. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Garcia-Bloj B, Moses C, Sgro A, Plani-Lam
J, Arooj M, Duffy C, Thiruvengadam S, Sorolla A, Rashwan R, Mancera
RL, et al: Waking up dormant tumor suppressor genes with zinc
fingers, TALEs and the CRISPR/dCas9 system. Oncotarget.
7:60535–60554. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Bernstein DL, Le Lay JE, Ruano EG and
Kaestner KH: TALE-mediated epigenetic suppression of CDKN2A
increases replication in human fibroblasts. J Clin Invest.
125:1998–2006. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Ke Q, Li W, Lai X, Chen H, Huang L, Kang
Z, Li K, Ren J, Lin X, Zheng H, et al: TALEN-based generation of a
cynomolgus monkey disease model for human microcephaly. Cell Res.
26:1048–1061. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Whyte JM, Ellis JJ, Brown MA and Kenna TJ:
Best practices in DNA methylation: Lessons from inflammatory bowel
disease, psoriasis and ankylosing spondylitis. Arthritis Res Ther.
21:1332019. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Liu B, Dong K and Dong R: The diagnosis
effect of DNA methylation in inflammatory bowel diseases.
Gastroenterology. 155:2292018. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
McLarty J and Yeh C: Circulating cell-free
DNA: The blood biopsy in cancer management. MOJ Cell Sci Rep.
2:000212015.
|
|
167
|
Hirahata T, Ul Quraish R, Quraish AU, Ul
Quraish S, Naz M and Razzaq MA: Liquid biopsy: A distinctive
approach to the diagnosis and prognosis of cancer. Cancer Inform.
21:117693512210760622022. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Karatzas PS, Gazouli M, Safioleas M and
Mantzaris GJ: DNA methylation changes in inflammatory bowel
disease. Ann Gastroenterol. 27:125–132. 2014.PubMed/NCBI
|
|
169
|
Warnecke PM, Stirzaker C, Melki JR, Millar
DS, Paul CL and Clark SJ: Detection and measurement of PCR bias in
quantitative methylation analysis of bisulphite-treated DNA.
Nucleic Acids Res. 25:4422–4426. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Raine A, Manlig E, Wahlberg P, Syvänen AC
and Nordlund J: SPlinted ligation adapter tagging (SPLAT), a novel
library preparation method for whole genome bisulphite sequencing.
Nucleic Acids Res. 45:e362017. View Article : Google Scholar :
|
|
171
|
Tost J: Current and emerging technologies
for the analysis of the genome-wide and locus-specific DNA
methylation patterns. Adv Exp Med Biol. 1389:395–469. 2022.
View Article : Google Scholar : PubMed/NCBI
|
